These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7545481)

  • 21. Biodegradable microspheres of poly(DL-lactic acid) containing piroxicam as a model drug for controlled release via the parenteral route.
    Lalla JK; Sapna K
    J Microencapsul; 1993; 10(4):449-60. PubMed ID: 8263674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of spray drying as a method for polylactide and polylactide-co-glycolide microsphere preparation.
    Pavanetto F; Genta I; Giunchedi P; Conti B
    J Microencapsul; 1993; 10(4):487-97. PubMed ID: 8263677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlled release of 3',5'-diester prodrugs of 5-fluoro-2'-deoxyuridine from poly-L-lactic acid microspheres.
    Seki T; Kawaguchi T; Endoh H; Ishikawa K; Juni K; Nakano M
    J Pharm Sci; 1990 Nov; 79(11):985-7. PubMed ID: 2149864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro extended-release properties of drug-loaded poly(DL-lactic acid) nanoparticles produced by a salting-out procedure.
    Allémann E; Leroux JC; Gurny R; Doelker E
    Pharm Res; 1993 Dec; 10(12):1732-7. PubMed ID: 7905625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation, characterization, cytotoxicity and transfection efficiency of poly(DL-lactide-co-glycolide) and poly(DL-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA.
    Basarkar A; Devineni D; Palaniappan R; Singh J
    Int J Pharm; 2007 Oct; 343(1-2):247-54. PubMed ID: 17611054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single processing step toward injectable sustained-release formulations of Triptorelin based on a novel degradable semi-solid polymer.
    Asmus LR; Kaufmann B; Melander L; Weiss T; Schwach G; Gurny R; Möller M
    Eur J Pharm Biopharm; 2012 Aug; 81(3):591-9. PubMed ID: 22561956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poly(lactic acid)/chitosan hybrid nanoparticles for controlled release of anticancer drug.
    Wang W; Chen S; Zhang L; Wu X; Wang J; Chen JF; Le Y
    Mater Sci Eng C Mater Biol Appl; 2015 Jan; 46():514-20. PubMed ID: 25492016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(3):297-325. PubMed ID: 2200861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained drug release characteristics of biodegradable composite poly(d,l)lactic acid-poly(l)lactic acid microcapsules containing ciprofloxacin.
    Yu WP; Wong JP; Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2000 Jan; 28(1):39-55. PubMed ID: 10676576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study on the in vitro degradation of poly(lactic acid).
    Migliaresi C; Fambri L; Cohn D
    J Biomater Sci Polym Ed; 1994; 5(6):591-606. PubMed ID: 8086385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Degradation of polydispersed poly(L-lactic acid) to modulate lactic acid release.
    von Recum HA; Cleek RL; Eskin SG; Mikos AG
    Biomaterials; 1995 Apr; 16(6):441-7. PubMed ID: 7654870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained release of insulin by double-layered implant using poly(D,L-lactic acid).
    Yamakawa I; Kawahara M; Watanabe S; Miyake Y
    J Pharm Sci; 1990 Jun; 79(6):505-9. PubMed ID: 2203895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biodegradation of PLA/GA polymers: increasing complexity.
    Vert M; Mauduit J; Li S
    Biomaterials; 1994 Dec; 15(15):1209-13. PubMed ID: 7703316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of thermal treatment on the physical-mechanical and dissolution properties of tablets containing poly(DL-lactic acid).
    Omelczuk MO; McGinity JW
    Pharm Res; 1993 Apr; 10(4):542-8. PubMed ID: 8483836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres.
    Blanco-Príeto MJ; Campanero MA; Besseghir K; Heimgatner F; Gander B
    J Control Release; 2004 May; 96(3):437-48. PubMed ID: 15120900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preparation of ibuprofen/sPEG-b-PLLA copolymer microspheres and its in vitro release properties].
    Lin YL; Zhang AQ; Guan FY; Chen YD; Tan WA; Wang LS
    Yao Xue Xue Bao; 2010 Dec; 45(12):1570-5. PubMed ID: 21351499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation of polylactic acid microcapsules containing ciprofloxacin.
    Yu WP; Wong JP; Chang TM
    J Microencapsul; 1998; 15(4):515-23. PubMed ID: 9651872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and evaluation of biodegradable microspheres containing a new potent osteogenic compound and new synthetic polymers for sustained release.
    Umeki N; Sato T; Harada M; Takeda J; Saito S; Iwao Y; Itai S
    Int J Pharm; 2010 Jun; 392(1-2):42-50. PubMed ID: 20227474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of polymer glass transition temperature and molecular weight on drug release from tablets containing poly(DL-lactic acid).
    Omelczuk MO; McGinity JW
    Pharm Res; 1992 Jan; 9(1):26-32. PubMed ID: 1589405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
    Jackson JK; Hung T; Letchford K; Burt HM
    Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.